12/17
08:15 am
tmdx
TransMedics Group, Inc. (NASDAQ: TMDX) had its "neutral" rating re-affirmed by analysts at JPMorgan Chase & Co.. They now have a $75.00 price target on the stock, down previously from $116.00.
Medium
Report
TransMedics Group, Inc. (NASDAQ: TMDX) had its "neutral" rating re-affirmed by analysts at JPMorgan Chase & Co.. They now have a $75.00 price target on the stock, down previously from $116.00.
12/17
06:58 am
tmdx
Rating for TMDX
Medium
Report
Rating for TMDX
12/17
05:18 am
tmdx
TransMedics downgraded to Neutral from Overweight at JPMorgan
Medium
Report
TransMedics downgraded to Neutral from Overweight at JPMorgan
12/11
08:21 am
tmdx
TransMedics Group, Inc. (NASDAQ: TMDX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
Low
Report
TransMedics Group, Inc. (NASDAQ: TMDX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
12/11
07:17 am
tmdx
Rating for TMDX
Low
Report
Rating for TMDX
12/11
07:17 am
tmdx
Rating for TMDX
Low
Report
Rating for TMDX
12/11
06:30 am
tmdx
Rating for TMDX
Low
Report
Rating for TMDX
12/11
06:30 am
tmdx
Rating for TMDX
Low
Report
Rating for TMDX
12/3
10:15 am
tmdx
TransMedics Group, Inc. (NASDAQ: TMDX) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $125.00 price target on the stock.
Medium
Report
TransMedics Group, Inc. (NASDAQ: TMDX) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $125.00 price target on the stock.
12/3
09:58 am
tmdx
Rating for TMDX
Medium
Report
Rating for TMDX
12/3
09:58 am
tmdx
Rating for TMDX
Medium
Report
Rating for TMDX
12/3
09:03 am
tmdx
TransMedics Group, Inc. (NASDAQ: TMDX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
Medium
Report
TransMedics Group, Inc. (NASDAQ: TMDX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
12/3
05:07 am
tmdx
Rating for TMDX
Medium
Report
Rating for TMDX
12/3
05:07 am
tmdx
Rating for TMDX
Medium
Report
Rating for TMDX
11/22
08:13 am
tmdx
TransMedics Group, Inc. (NASDAQ: TMDX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC. They now have a $109.00 price target on the stock.
Low
Report
TransMedics Group, Inc. (NASDAQ: TMDX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC. They now have a $109.00 price target on the stock.
11/22
05:18 am
tmdx
Rating for TMDX
Low
Report
Rating for TMDX
11/22
05:18 am
tmdx
Rating for TMDX
Low
Report
Rating for TMDX
11/20
09:27 am
tmdx
Rating for TMDX
Medium
Report
Rating for TMDX
10/29
11:10 am
tmdx
Rating for TMDX
Report
Rating for TMDX
10/29
09:21 am
tmdx
Rating for TMDX
Medium
Report
Rating for TMDX
10/29
09:21 am
tmdx
Rating for TMDX
Medium
Report
Rating for TMDX
10/29
08:13 am
tmdx
Rating for TMDX
Medium
Report
Rating for TMDX
10/29
08:00 am
tmdx
Rating for TMDX
Medium
Report
Rating for TMDX
10/29
08:00 am
tmdx
Rating for TMDX
Medium
Report
Rating for TMDX
10/29
06:38 am
tmdx
Rating for TMDX
Medium
Report
Rating for TMDX